Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial

Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-03T11:48:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T02:24:10.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-11T20:26:45.000Z thumbnail image
  5. Check
    31 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-28T12:56:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T00:20:44.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase 1B study on Renal Cell Carcinoma, with changes in the study's description and collaborators. The principal investigator's name, Neeraj Agarwal, MD, has been retained, but the previous detailed inclusion and exclusion criteria have been removed.
    Difference
    40%
    Check dated 2025-04-22T20:51:32.000Z thumbnail image

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.